Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2025 08:00 ET | Source: Certara

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
January 23, 2025 09:30 ET | Source: Straits Research Private Limited - Garner Insights

Biosimilars Market Size is Projected to Reach USD 121.88 Billion by 2033, Growing at a CAGR of 15.56%: Straits Research

New York, United States, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Biosimilars, also known as follow-on biologics, are made by a different business but look and work much like the original medicine....
December 23, 2024 09:20 ET | Source: Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment

PRINCETON, NJ, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic...
November 19, 2024 06:30 ET | Source: Global Market Insights Inc.

Immunomodulators Market to hit USD 388.7 billion by 2032, says Global Market Insights Inc.

Selbyville, Delaware, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Immunomodulators Market size was valued at approximately USD 217.7 billion in 2023 and is projected to grow at a CAGR of 6.7% from 2024 to...
November 12, 2024 07:30 ET | Source: FACT.MR

Cryoglobulinemic Vasculitis Market is Forecasted to Reach $930.1 Million by 2034, Growing at 6.9% CAGR | Fact.MR Report

Rockville, MD, Nov. 12, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global Cryoglobulinemic vasculitis market is estimated to reach a...
September 25, 2024 08:30 ET | Source: Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted...
September 18, 2024 08:00 ET | Source: Certara

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.
June 21, 2022 08:00 ET | Source: Certara

Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics

PRINCETON, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Certara Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of new versions of its Immunogenicity (IG),...
October 29, 2020 10:00 ET | Source: SomaLogic, Inc.

SomaLogic Announces New Collaboration with FDA to Advance Biosimilar Development

BOULDER, Colo., Oct. 29, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc. announced today an agreement with the US Food and Drug Administration (FDA)’s Division of Applied Regulatory Science to evaluate the...
March 19, 2019 11:34 ET | Source: Reports And Data

Biosimilars Market To Reach USD 44.56 Billion By Year 2026 | Reports And Data

Market Size – USD 5.10 Billion in 2018, Market Growth - CAGR of 30.8%, Market Trends – Product launches and research for advanced Biosimilars NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- ...